KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zimmer Biomet Holdings (ZBH) Equity Ratio (2016 - 2026)

Zimmer Biomet Holdings has reported Equity Ratio over the past 18 years, most recently at 0.56 for Q1 2026.

  • For Q1 2026, Equity Ratio changed 0.18% year-over-year to 0.56; the TTM value through Mar 2026 reached 0.56, changed 0.18%, while the annual FY2025 figure was 0.55, 5.77% down from the prior year.
  • Equity Ratio for Q1 2026 was 0.56 at Zimmer Biomet Holdings, up from 0.55 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.59 in Q2 2024 and troughed at 0.54 in Q3 2025.
  • A 5-year average of 0.57 and a median of 0.57 in 2022 define the central range for Equity Ratio.
  • Biggest five-year swings in Equity Ratio: grew 8.8% in 2022 and later fell 7.47% in 2025.
  • Year by year, Equity Ratio stood at 0.57 in 2022, then increased by 1.75% to 0.58 in 2023, then increased by 0.52% to 0.58 in 2024, then decreased by 5.77% to 0.55 in 2025, then grew by 1.44% to 0.56 in 2026.
  • Business Quant data shows Equity Ratio for ZBH at 0.56 in Q1 2026, 0.55 in Q4 2025, and 0.54 in Q3 2025.